Skip Navigation

Medication Development for Drug Use Disorders

Kelly Dunn, Ph.D., M.B.A., M.S.

Principal Investigator:
Kelly Dunn, Ph.D., M.B.A., M.S.
Department:
Neurology

Our lab evaluates new medications and/or techniques for the treatment of drug use disorder by conducting human laboratory studies to sensitively assess drug effects, and randomized controlled trial evaluations of medications for clinical treatment outcomes. We also focus on the development of outcome measures that are sensitive and clinically relevant.

Research Areas: opioids, smoking cessation, alcohol, alcohol use, alcoholism

Find a Research Lab
Edit lab profile

back to top button